U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
180451180451Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children.CompletedNo Results AvailableInfluenzaBiological: CAIV-Thttps://ClinicalTrials.gov/show/NCT00192426
180452180452Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed InfluenzaCompletedNo Results AvailableInfluenzaBiological: Cold-adapted influenza vaccine trivalent (CAIV-T)|Biological: Trivalent Inactivated Vaccine (TIV)https://ClinicalTrials.gov/show/NCT00192413
180453180453Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.CompletedNo Results AvailableHealthyBiological: CAIV-Thttps://ClinicalTrials.gov/show/NCT00192400
180454180454Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)CompletedNo Results AvailableInfluenzaBiological: CAIV-T, Liquidhttps://ClinicalTrials.gov/show/NCT00192387
180455180455Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy ChildrenCompletedNo Results AvailableHealthyBiological: CAIV-T, Liquidhttps://ClinicalTrials.gov/show/NCT00192374
180456180456Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)CompletedNo Results AvailableInfluenzaBiological: CAIV-Thttps://ClinicalTrials.gov/show/NCT00192361
180457180457A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine,(CAIV-T) in Healthy InfantsCompletedNo Results AvailableHealthyBiological: CAIV-Thttps://ClinicalTrials.gov/show/NCT00192348
180458180458Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy ParticipantsCompletedNo Results AvailableHealthyBiological: CAIV-T|Biological: CAIVT|Biological: FluMisthttps://ClinicalTrials.gov/show/NCT00192335
180459180459Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy ChildrenCompletedNo Results AvailableInfluenzaBiological: CAIV-T 10^7|Biological: CAIVT 10^5|Biological: Placebo|Biological: TIVhttps://ClinicalTrials.gov/show/NCT00192322
180460180460Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.CompletedNo Results AvailableInfluenzaBiological: CAIV-T|Biological: TIV|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00192309
180461180461Study to Evaluate the Safety, Tolerability,Immunogenicity, and Pharmacokinetics of MEDI-528 in Healthy Adult VolunteersCompletedHas ResultsAsthmaBiological: MEDI-528 0.3 mg/kg|Biological: MEDI-528 1 mg/kg|Biological: MEDI-528 3 mg/kg|Biological: MEDI-528 9 mg/kghttps://ClinicalTrials.gov/show/NCT00192296
180462180462Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care CentersCompletedNo Results AvailableInfluenzaBiological: CAIV-T|Other: Placebohttps://ClinicalTrials.gov/show/NCT00192283
180463180463Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy ChildrenCompletedNo Results AvailableHealthyBiological: CAIV-Thttps://ClinicalTrials.gov/show/NCT00192270
180464180464Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With AsthmaCompletedNo Results AvailableAsthmaBiological: CAIV-T and TIVhttps://ClinicalTrials.gov/show/NCT00192257
180465180465Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy ChildrenCompletedNo Results AvailableHealthyBiological: CAIV-T, Liquidhttps://ClinicalTrials.gov/show/NCT00192244
180466180466Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T)CompletedNo Results AvailableInfluenzaBiological: CAIV-Thttps://ClinicalTrials.gov/show/NCT00192231
180467180467Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention ProgramCompletedNo Results AvailableInfluenzaBiological: FluMisthttps://ClinicalTrials.gov/show/NCT00192218
180468180468Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in ChildrenCompletedNo Results AvailableRespiratory Tract InfectionsBiological: CAIV-T or TIVhttps://ClinicalTrials.gov/show/NCT00192205
180469180469Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy AdultsCompletedNo Results AvailableInfluenzaBiological: CAIV-Thttps://ClinicalTrials.gov/show/NCT00192192
180470180470A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.CompletedNo Results AvailableInfluenzaBiological: Cold-adapted influenza vaccine trivalent (CAIV-T)|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00192179
180471180471Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24CompletedNo Results AvailableInfluenzaBiological: CAIV-Thttps://ClinicalTrials.gov/show/NCT00192166
180472180472Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and OlderCompletedNo Results AvailableInfluenzaBiological: CAIV-T or TIVhttps://ClinicalTrials.gov/show/NCT00192153
180473180473Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of AgeCompletedNo Results AvailableInfluenzaBiological: FluMisthttps://ClinicalTrials.gov/show/NCT00192140
180474180474Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy AdultsCompletedNo Results AvailableInfluenzaBiological: FluMist|Other: Placebohttps://ClinicalTrials.gov/show/NCT00192127
180475180475Enzastaurin for Patients With Metastatic Colorectal CancerCompletedNo Results AvailableColonic NeoplasmsDrug: Enzastaurin HClhttps://ClinicalTrials.gov/show/NCT00192114
180476180476Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or TaxanesCompletedNo Results AvailableMetastatic Breast CancerDrug: gemcitabine|Drug: cisplatinhttps://ClinicalTrials.gov/show/NCT00192101
180477180477A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric CarcinomaCompletedNo Results AvailableAdvanced Gastric CarcinomaDrug: pemetrexed|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00192088
180478180478A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal CancerCompletedHas ResultsColorectal CancerDrug: Gemcitabine|Drug: avastin|Drug: 5FU/folinic acid|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00192075
180479180479A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast CancerCompletedNo Results AvailableBreast CancerDrug: gemcitabine|Drug: vinorelbinehttps://ClinicalTrials.gov/show/NCT00192062
180480180480A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder CancerCompletedNo Results AvailableSuperficial Bladder CancerDrug: Gemcitabine|Drug: mitomycin Chttps://ClinicalTrials.gov/show/NCT00192049

* Görseller ve İçerik tekif hakkına sahip olabilir